Literature DB >> 7430185

Changes in tissue morphology and collagen composition during the repair of cortical bone in the adult chicken.

M J Glimcher, F Shapiro, R D Ellis, D R Eyre.   

Abstract

UNLABELLED: An animal model was developed to study the histology and collagen chemistry of healing cortical bone. A hole was cut through the cortex of the mid-shaft of the humerus of the adult chicken, which allowed for repair at a mechanically stable site. After one to two weeks the collagen of the repair tissue, which consisted principally of woven bone, contained almost three times as much hydroxylysine as the collagen of normal adult bone and thus resembled the collagen of embryonic long bones. By eight weeks, when lamellar one predominated, the hydroxylysine content had fallen to normal levels. Type I was the major genetic type of collagen present throughout. No type-II collagen, characteristic of cartilage, was detected; this was consistent with the histological findings. The results established that hydroxylysine-rich type-I collagen can be made by osteoblasts of adult animals as well as by those of embryos and early postnates. CLINICAL RELEVANCE: In order to understand the biological characteristics of fracture healing, it is vital to study not only the macroscopic organization of the repair tissue but also the chemical properties of its molecular components. The strength of healing fractured bone, and indeed of normal bone, depends largely on the properties of the structural protein collagen. To date, it is not known whether the collagen in healing fractures is the same as that in normal bone, or whether it has distinct chemical features that may suit it for bone repair.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7430185

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  8 in total

1.  Lysyl hydroxylation in collagens from hyperplastic callus and embryonic bones.

Authors:  H W Lehmann; M Bodo; C Frohn; A Nerlich; D Rimek; H Notbohm; P K Müller
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Association of PLOD1 polymorphisms with bone mineral density in a population-based study of women from the UK.

Authors:  P N Tasker; H Macdonald; W D Fraser; D M Reid; S H Ralston; O M E Albagha
Journal:  Osteoporos Int       Date:  2006-05-04       Impact factor: 4.507

3.  Osseointegration improves bone-implant interface of pedicle screws in the growing spine: a biomechanical and histological study using an in vivo immature porcine model.

Authors:  Kanako Shiba; Hiroshi Taneichi; Takashi Namikawa; Satoshi Inami; Daisaku Takeuchi; Yutaka Nohara
Journal:  Eur Spine J       Date:  2017-04-08       Impact factor: 3.134

4.  A new sheep model with automatized analysis of biomaterial-induced bone tissue regeneration.

Authors:  L M Atayde; P P Cortez; T Pereira; P A S Armada-da-Silva; A Afonso; M A Lopes; J D Santos; A C Maurício
Journal:  J Mater Sci Mater Med       Date:  2014-04-27       Impact factor: 3.896

5.  Analysis of cyanogen bromide peptides of type I collagen from a patient with lethal osteogenesis imperfecta.

Authors:  E Kirsch; R W Glanville; T Krieg; P Müller
Journal:  Biochem J       Date:  1983-06-01       Impact factor: 3.857

6.  Lysylhydroxylation and non-reducible crosslinking of human supraspinatus tendon collagen: changes with age and in chronic rotator cuff tendinitis.

Authors:  R A Bank; J M TeKoppele; G Oostingh; B L Hazleman; G P Riley
Journal:  Ann Rheum Dis       Date:  1999-01       Impact factor: 19.103

7.  The post-translational phenotype of collagen synthesized by SAOS-2 osteosarcoma cells.

Authors:  Russell J Fernandes; Michael A Harkey; Maryann Weis; Jennifer W Askew; David R Eyre
Journal:  Bone       Date:  2007-01-25       Impact factor: 4.398

8.  Biochemical analysis of callus tissue in osteogenesis imperfecta type IV. Evidence for transient overmodification in collagen types I and III.

Authors:  R E Brenner; U Vetter; A Nerlich; O Wörsdorfer; W M Teller; P K Müller
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.